UK Stock Market News
Sharesify podcast with Adam Norris of CT Global Managed Portfolio Trust
In this special episode of the podcast, Ian and James are joined by Adam Norris, who manages the CT Global
Eagle Eye results herald a bright future in store
Full-year results from AI-powered loyalty and promotions firm Eagle Eye Solutions (LON:EYE) beat previously raised expectations, heralding a bright future.
How to invest in technology stocks: A UK beginner’s guide 2026
Investing in technology stocks can give UK investors exposure to long-term growth areas, such as artificial intelligence, cloud computing, semiconductors,
Trustpilot H1 2026 results: Why the shares are crashing
Online reviews platform Trustpilot (LON:TRST) saw its shares fall under heavy pressure after the company reported its H1 2026 results
Kier upgrades FY27 earnings guidance as order book grows
Infrastructure services-to-construction company Kier (LON:KIE) reported forecast-beating FY26 results and upgraded FY27 guidance. Earnings for the current year will be at
Resilient Wickes rallies on ‘significantly improved’ Q3 trading
Shares in Wickes (LON:WIX) rallied after the home improvement retailer reported a ‘significantly improved’ trading trend in Q3-to-date. There was
Personal Group growth boosted by insurance sales
AIM-listed workplace benefits and insurance provider Personal Group (LON:PGH) posted strong growth in H1 revenue boosted by new insurance sales.
RTW Biotech Opportunities delivers healthy 16.5% return
Investment trust RTW Biotech Opportunities (LON:RTW) generated a healthy net asset value (NAV) total return of 16.5% for the six
Sharesify podcast with Gabriel Sacks of Aberdeen Asia Focus
In this special episode of the podcast, we’re joined by Gabriel Sacks, manager of Aberdeen Asia Focus (LON:AAS). The investment
MP Evans rallies on record results and robust pricing outlook
Shares in MP Evans (LON:MPE) tested new all-time highs after the sustainable Indonesian palm oil producer posted record H1 results.
GSK gains on positive trial results for new cancer drugs
Shares in pharmaceutical giant GSK (LON:GSK) gained on positive trial results for two of its new cancer drugs. The company
Sharesify podcast with Jean Roche of Schroder UK Mid Cap Fund
In this special edition of the podcast, we’re joined by Jean Roche, manager of the Schroder UK Mid Cap Fund
Coming next week: Next, Trustpilot, Barratt Redrow
The week of 14–18 September 2026 brings a busy run of UK company results, with several reports likely to attract
Sharesify podcast 11 September 2026
In the latest episode of the podcast, the Sharesify gang talk markets climbing a wall of worry, tech earnings and
Lindsell Train Investment Trust launches 20% tender offer
Out-of-favour investment trust Lindsell Train (LON:LTI) has launched a tender offer for up to 20% of the company at a
Oracle Q1 2027 earnings: Stock soars as AI surge drives record $664bn backlog
Oracle (NYSE:ORCL) delivered a much stronger-than-expected first quarter, with accelerating AI cloud growth and a record $664bn backlog helping drive
Premium
Research
